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Here we report the results of this study and propose reasonable steps to improve the validity of the various assay systems applied.
Materials and Methods

Chemicals:
25-OH-D2was kindly provided by Dr. J.
Babcock, Upjohn Co., Kalamazoo,
MI. All other vitamin D
compounds were a gift of Dr. M. Uskokovic, Hoffmann-La Roche, Nutley, NJ. All compounds were in ethanolic solution and exhibited the characteristic ultraviolet absorption,
with a maximum at 265 nm and a minimum at 228 nm, indicative of the intact vitamin D 5,6-cis-triene chromephore and of the purity of the compounds. Their concentration was calculated from their absorption at 265 nm, assuming a molar absorptivity (1) of 18300 LImol.
Renwval of endogenous vitamin D from bovine serum:
We shook 1 L of bovine serum horizontally, at room temperature, with 120 g of activated charcoal (Norit A; Serva Chemicals, Heidelberg, F.R.G.) for 48 h. The charcoal was then allowed to sediment and the supernate was centrifuged (5000 x g, 30 mm). After filtration, we again centrifuged and filtered the serum. The clear filtrate was divided into 11 equal parts, to which we added defined amounts of 25-OH-D3, 25-OH-D2, vitamin D3, 24,25(OH)2D3, or 1,25(OH)2D3. The sera were carefully mixed and allowed to equilibrate for 1 h. Then, 2-mL aliquots were stored at -20 #{176}C.
Test sera ( 
Results
Reproducibility:
To investigate the reproducibility of the assays applied, we included samples 1-3 (sera from healthy volunteers) and sample no. 7 (serum from a patient with hypoparathyroidism on treatment with vitamin D3) twice in the set of sera (respectively labeled 4, 5,6, and 20). Figure 1 depicts the 25-OH-D3 assay results for samples 4 and 1. This test serum was assayed only twice, so an intra-assay CV cannot be given. Nevertheless, it is apparent that the intraassay variation was quite low in most of the laboratories; almost identical results were obtained. In this respect, the results for the other set-duplicated samples were comparable (see Table 3 ).
Accuracy: Because we had no sera devoid of any vitamin D and its metabolites, we treated bovine serum with charcoal to remove endogenous vitamin D. After a procedure that included shaking the serum at room temperature for 48 h, ifitering, and centrifugation, a small amount of 25-OH-I)3 was still present. We measured in this sample (sample no.8) a concentration of 21 nmol of 25-OH-D3 per liter with the reference method.
This serum was divided into 11 equal parts and either increasing amounts of 25-OH-D3 or a single concentration of vitamin D3, 25-OH-I)2, 24,25-(OH)2D3, or 1,25(OH)2D3 was added. The presenceof the 25-OH-D3 serum standard curve was well recognized by the assays of most laboratories (see Figure 2 and Table 4 ). Indeed, the overall mean values obtained for samples 8-14 almost approach the trueconcentrations. However, the large average CV (55%) reflects the poor agreement among results obtained by the various laboratories. This is also illustrated by the results reported in Table 3 Lab. no.
other hand the precision was good for most of these laboratories.
On analyzing the data obtained by assays including a chromatographic step vs methods with no chromatography it becomes apparent that the latter measure about twice as much apparent 25-OH-D in all serum samples not pretreated with charcoal. This twofold difference appears to be independent of the actual 25-OH-D concentration, because it can be observed in samples both from normal subjects and from patients with very high 25-OH-I) concentrations as a result of treatment with pharmacological doses of vitamin D3 or vitamin D2 (see Table 3 ). To preparetest sample no. Consequently, high concentrations of this metabolite are detected in vitamin D intoxication, low ones in vitamin D deficiency. To test the validity of the 25-OH-D assays applied by the various collaborating laboratories, we included in the set of sera samples with high 25-OH-D3 or 25-OH-D2 content (derived from patients on vitamin D3 or D2 treatment), subnormal concentration (charcoal-treated bovine serum), and samples from healthy volunteers. The results (Figure 3) show that all laboratories could distinguish between the 25-OH-I) concentrations in the high-dose samples and those from normal subjects, but only eight laboratories could discriminate normal from subnormal values. (25) . These authors concluded that this discrepancy must originate from the different extraction and purification procedure used for the serum samples.
In our study, the 15 laboratories evaluated a test set of 23 sera, using their routine assays for 25-OH-I). The results show good reproducibility of 25-OH-D values in most laboratories, and all of them could distinguish between normal and grossly above-normal 25-OH-I) concentrations. In contrast, a sample with a subnormal 25-OH-I)3 content was reported to be within the normal range by seven laboratories, a result we believe is ascribable to nonspecific interference. Certainly, the subnormal range should be clearly distinguishable from the normal for diagnosis of vitamin I) deficiency.
The presence of compounds nonspecifically interfering at the DBP binding site is most clearly evident when methods were applied that omitted any chromatographic pre-assay purification. In this case, values were accureate for samples consisting of different amounts of 25-OH-I)3 added to charcoal-treated bovine serum, but the 25-OH-I) content of sera from healthy subjects or patients on high-dose vitamin D treatment was overestimated about twofold. Charcoal treatment of serum not only removes most endogenous 25-OH-D3, but also other substances such as Nat, C1, parathyrin, insulin, folic acid, uric acid, creatinine, and triiodothyronine (unpublished observation)-a list that obviously includes material interfering in nonchromatographic assays for 25-OH-D. This is most clearly illustrated by the results obmined by the various laboratories for samples 12 and 19. When the 25-OH-I)3 was increased by 200 nmol/L in charcoal-treated serum or in serum from a normal subject, direct assays measured 25-OH-D3 equally as well as chromatographic methods in charcoal-treated samples, but overestimated by twofold the 25-OH-I)3 concentration in the samples from a normal subject. Thus a chromatographic step (e.g., with silicic acid, Sephadex LH 20) apparently is desirable before radioassay for 25-OH-I)3. A direct assay would be an important improvement forroutine25-OH-D measurement, because itwould be far lesslaboriousand expensive. This, however, would requireelimination ofthe nonspecifically interfering material present in serum extracts. Recently, Bouillon (14) published a preliminary report that nonspecffic interference could be eliminated by an extraction procedure including saponification followed by extraction with n-hexane and including a 25-OH-I)3 standard curve prepared by using serum freed of vitamin I) by affinity chromatography. When this method was compared with a chromatographic procedure, the values correlated well (r = 0.96), but the absolute values were about 20% higher. Of course, in this assay system still other vitamin I) metabolites such as 24,25-(OH)2D, 25,26(OH)2D, and 25-OH-D-26,23-lactone will interfere. However, their concentrations in plasma are 20 to 100 times lower than those of 25-OH-I), and so in routine screening for vitamin I) deficiency and vitamin I) intoxication this slight overestimate as a consequence of specific interferences in the assay is not of major concern.
25-OH-D2 was not detectable in 15 sera from healthy volunteers as evaluated by a HPLC procedure for the simultaneous quantification of 25-OH-D2 and 25-OH-I)3. However, this compound reached a very high concentration in serum from a patient being treated with pharmacological doses of vitamin D2 (sample 23, see Table 3 ).
All but one laboratory used in their assays I)BP (from rat, rabbit, or human) that equally recognizes 25-OH-I)2 and 25-OH-I)3 (15, 16). Thus in fact, even when established for 25-OH-D3, their assays actually measure total 25-OH-I). One laboratory uses chickserum as a source of I)BP. Chick I)BP reportedlyrecognizes25-OH-I)2 15 times less avidly than it does 25-OH-I)3 (17) . Therefore, if differentiation between 25-OH-I)2 and 25-OH-I)3 is sought, chick DBP might be the protein of choice, but when measurement of total 25-OH-I) is desired, DBP from human, rat, or rabbit is preferable.
As an alternative approach to measure 25-OH-I), we applied HPLC and subsequent quantification of 25-OH-I)2 and 25-OH-D3 by their ultraviolet absorbance, finding the method to be accurate, precise, and specific. Results compared well with those by the best chromatographic-competitive protein binding assays. Furthermore, simultaneous separate determination of 25-OH-I)2 and 25-OH-D3 was possible. This method is laborious and expensive, so it is not applicable for routine 25-OH-D mesurement, but it served wellas a reference method forthisstudy.
From the resultsreported in this communication it is evidentthat interlaboratory variation in the measurement of 25-OH-D istoo wide for a comparison of assay results reported by different laboratories to be valid.To improve interlaboratory variation, we proposeeitherstandardization ofthe methods appliedor the introduction ofreference sera tocontrol therebyeach assay carried out. Because the latter procedure appearsmore promisingtous,we now preparea setofreference sera,which willbe shipped upon request to laboratories interested in 25-OH-I) measurement.
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